Increasing visibility with a proactive supply chain

Document

Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.
3 August 2020

What is on this page?

Click to jump to a specific section below.

Introduction

Our whole story starts here

Mission and vision

Logipharma report

The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data.

In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table.

CEO Niclas Ohlsson, share TSS's view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.

Highlights:

  • Recommendations on Implementing a Real-Time Monitoring Solution
  • A Glimpse into the Future of Pharma Logistics
  • The Evolving Digital Landscape
  • Increasing Visibility
  • Utilizing Real-Time Data

‍

Complete the form below to download a copy of the report.

‍


You may also be interested in

On-demand webinar: A unified approach to clinical supply temperature management

Automation of temperature excursion handling and data flow to streamline site activities
Read moreDownload Whitepaper
A person using a tablet with a high-tech interface, illustrating advanced data analysis for rapid decision-making.

How can maturity in temperature management move your decision process from days to seconds?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.
Read moreDownload Whitepaper

Covid-19 situation

The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.